Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
2.050
-0.020 (-0.97%)
At close: Aug 22, 2025, 4:00 PM
2.080
+0.030 (1.46%)
After-hours: Aug 22, 2025, 7:51 PM EDT
Ensysce Biosciences Market Cap
Ensysce Biosciences has a market cap or net worth of $6.09 million as of August 22, 2025. Its market cap has increased by 108.76% in one year.
Market Cap
6.09M
Enterprise Value
4.30M
1-Year Change
108.76%
Ranking
Category
Stock Price
$2.05
Market Cap Chart
Since February 26, 2018, Ensysce Biosciences's market cap has decreased from $59.64B to $6.09M, a decrease of -99.99%. That is a compound annual growth rate of -70.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 6.09M | -42.71% |
| Dec 31, 2024 | 10.62M | 218.52% |
| Dec 29, 2023 | 3.33M | -30.67% |
| Dec 30, 2022 | 4.81M | -95.78% |
| Dec 31, 2021 | 113.99M | -99.39% |
| Dec 31, 2020 | 18.67B | 21.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 637.23B |
| Johnson & Johnson | 430.92B |
| AbbVie | 370.09B |
| UnitedHealth Group | 274.74B |
| AstraZeneca | 250.88B |
| Novartis AG | 246.51B |
| Novo Nordisk | 246.31B |
| Abbott Laboratories | 229.74B |